Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 11Unknown 5Recruiting 4Terminated 3Not yet recruiting 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Breast 2

Conditions

Leukemia, Myeloid, Acute 2Triple Negative Breast Neoplasms 1HER2-negative Breast Cancer 1Breast Neoplasms 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Interventional × Anthracyclines × Clear all
NCT07548710 2026-04-23

Study of SA+X in the Treatment of Newly Diagnosed AML

Ruijin Hospital

Phase 2 Recruiting
205 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06802757 2026-02-25

PRISM-TNBC

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
72 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06451861 2025-11-17

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Guangdong Provincial People's Hospital

Phase 2 Recruiting
240 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06102824 2024-11-25

ORIENTA

Guangdong Provincial People's Hospital

Phase 2 Recruiting
252 enrolled
Breast

HER2-negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡